Súil Delgado-Collins

She specializes in pricing and market access, value perception, and pipeline strategy. Since joining CRA, Súil has led and contributed to diverse strategic projects, delivering tailored and high-impact solutions to complex client challenges.

Súil has experience across a wide range of therapeutic areas, including neurology, rare disease, oncology, autoimmune, and infectious disease. She has a particular interest in neurodegenerative diseases, building on her doctoral research at the University of Cambridge, investigating the development of small molecule therapies for amyloidogenic disease.

Súil prides herself on her ability to foster genuine collaboration and synergistic thinking across cross-functional and global teams, enabling the delivery of practical, high-quality outcomes for clients.